Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt
Sponsor
Ain Shams University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04569955
Collaborator
(none)
300
1
4.4
68.1
Study Details
Study Description
Brief Summary
-
Clinical trials are essential to translate new therapy concepts or rather any intervention into the medical routine. Beside the well designed trial protocol, the success of clinical trials depends on patient recruitment and participation.
-
This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
300 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Knowledge and Perception of Clinical Trial Participation in Breast Cancer Female Patients in Egypt, a Cross Sectional Study
Actual Study Start Date
:
Jul 20, 2020
Anticipated Primary Completion Date
:
Dec 1, 2020
Anticipated Study Completion Date
:
Dec 1, 2020
Outcome Measures
Primary Outcome Measures
- The percentage of breast cancer patients who accept to participate in clinical trials [1 year]
Secondary Outcome Measures
- The barriers for participation in clinical trials [1 year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Female breast cancer patients
Exclusion Criteria:
- Patients who refuse participation
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Ain shams university, faculty of medicine | Cairo | Select | Egypt | 1667 |
Sponsors and Collaborators
- Ain Shams University
Investigators
- Principal Investigator: Hagar Elghazawy, Ain shams university, faculty of medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hagar Elghazawy,
Lecturer of clinical oncology,
Ain Shams University
ClinicalTrials.gov Identifier:
NCT04569955
Other Study ID Numbers:
- FMASU R61/2020
First Posted:
Sep 30, 2020
Last Update Posted:
Sep 30, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: